AzurRx BioPharma Statistics Share Statistics AzurRx BioPharma has 995K
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 995K Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 784.8K Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 249.8K, so 0% of the outstanding
shares have been sold short.
Short Interest 249.8K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.64 and the forward
PE ratio is null.
AzurRx BioPharma's PEG ratio is
0.13.
PE Ratio -1.64 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -20.33 P/FCF Ratio -4.78 PEG Ratio 0.13
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AzurRx BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.51,
with a Debt / Equity ratio of 0.
Current Ratio 0.51 Quick Ratio 0.51 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -4.53
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.72M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -398.08K Effective Tax Rate 1.22%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.51, so AzurRx BioPharma's
price volatility has been higher than the market average.
Beta 1.51 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 713,030
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.43M Net Income -32.67M EBITDA -26.83M EBIT -26.83M Earnings Per Share (EPS) -5.9
Full Income Statement Balance Sheet The company has 6.06K in cash and 0 in
debt, giving a net cash position of 6.06K.
Cash & Cash Equivalents 6.06K Total Debt n/a Net Cash n/a Retained Earnings n/a Total Assets 13.78M Working Capital 2.16M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.22M
and capital expenditures -4.17K, giving a free cash flow of -11.23M.
Operating Cash Flow -11.22M Capital Expenditures -4.17K Free Cash Flow -11.23M FCF Per Share -2.03
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AZRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for AZRX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 13, 2021. It was a
backward
split with a ratio of 1:10.
Last Split Date Sep 13, 2021 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -15.27 Piotroski F-Score 2
